470 related articles for article (PubMed ID: 19141073)
1. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
[TBL] [Abstract][Full Text] [Related]
2. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
[TBL] [Abstract][Full Text] [Related]
3. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
[TBL] [Abstract][Full Text] [Related]
4. Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.
Forsberg A; Juréus A; Cselényi Z; Eriksdotter M; Freund-Levi Y; Jeppsson F; Swahn BM; Sandell J; Julin P; Schou M; Andersson J; Johnström P; Varnäs K; Halldin C; Farde L; Svensson S
Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):580-93. PubMed ID: 23324871
[TBL] [Abstract][Full Text] [Related]
5. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
[TBL] [Abstract][Full Text] [Related]
6. Distinct binding of amyloid imaging ligands to unique amyloid-β deposited in the presubiculum of Alzheimer's disease.
Ji B; Chen CJ; Bando K; Ashino H; Shiraishi H; Sano H; Kasahara H; Minamizawa T; Yamada K; Ono M; Zhang MR; Seki C; Farde L; Suhara T; Higuchi M
J Neurochem; 2015 Dec; 135(5):859-66. PubMed ID: 26315807
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys.
Andersson JD; Varnäs K; Cselényi Z; Gulyás B; Wensbo D; Finnema SJ; Swahn BM; Svensson S; Nyberg S; Farde L; Halldin C
Synapse; 2010 Oct; 64(10):733-41. PubMed ID: 20698029
[TBL] [Abstract][Full Text] [Related]
8. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
[TBL] [Abstract][Full Text] [Related]
9. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
10. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer ¹¹C-AZD2184.
Ito H; Shimada H; Shinotoh H; Takano H; Sasaki T; Nogami T; Suzuki M; Nagashima T; Takahata K; Seki C; Kodaka F; Eguchi Y; Fujiwara H; Kimura Y; Hirano S; Ikoma Y; Higuchi M; Kawamura K; Fukumura T; Böö ÉL; Farde L; Suhara T
J Nucl Med; 2014 Jun; 55(6):932-8. PubMed ID: 24732152
[TBL] [Abstract][Full Text] [Related]
12. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
[TBL] [Abstract][Full Text] [Related]
13. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
[TBL] [Abstract][Full Text] [Related]
14. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
15. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
[TBL] [Abstract][Full Text] [Related]
16. 11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous.
Abrahamson EE; Kofler JK; Becker CR; Price JC; Newell KL; Ghetti B; Murrell JR; McLean CA; Lopez OL; Mathis CA; Klunk WE; Villemagne VL; Ikonomovic MD
Brain; 2022 Jun; 145(6):2161-2176. PubMed ID: 34918018
[TBL] [Abstract][Full Text] [Related]
17. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease.
Higuchi M
Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
[TBL] [Abstract][Full Text] [Related]
19. Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.
Nyberg S; Jönhagen ME; Cselényi Z; Halldin C; Julin P; Olsson H; Freund-Levi Y; Andersson J; Varnäs K; Svensson S; Farde L
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1859-63. PubMed ID: 19495746
[TBL] [Abstract][Full Text] [Related]
20. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
Ni R; Gillberg PG; Bogdanovic N; Viitanen M; Myllykangas L; Nennesmo I; Långström B; Nordberg A
Alzheimers Dement; 2017 Apr; 13(4):419-430. PubMed ID: 27693181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
